Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4nka | 2K7 | Fibroblast growth factor receptor 1 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 1.000 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.554 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.543 | |
2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.534 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.534 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.532 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.528 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.525 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.524 | |
3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.521 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.513 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.512 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.507 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.499 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.498 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.498 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.497 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.493 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.490 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.487 | |
1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.487 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.486 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.486 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.485 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.484 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.482 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.481 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.480 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.480 | |
4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.479 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.479 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.476 | |
3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.475 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.474 | |
3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.473 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.473 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.473 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.471 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.471 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.471 | |
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.470 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.469 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.468 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.468 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.467 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.467 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.467 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.467 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.466 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.466 | |
4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.465 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.464 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.464 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.464 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.463 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.463 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.463 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.463 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.463 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.462 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.460 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.460 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.460 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.459 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.459 | |
4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.458 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.456 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.456 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.456 | |
3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.456 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.456 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.455 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.455 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.455 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.455 | |
3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.455 | |
3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.455 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.454 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.453 | |
3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.453 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.453 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.453 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.453 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.453 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.452 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.452 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.452 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.451 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.451 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.451 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.451 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.450 | |
3vnt | 0JA | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.450 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.450 | |
4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
2e9c | B75 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.449 | |
3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.449 | |
3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.449 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.448 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.447 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.447 | |
5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.447 | |
2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.446 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
1agw | SU2 | Fibroblast growth factor receptor 1 | / | 0.445 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.445 | |
2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.445 | |
3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.445 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.445 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.444 | |
3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.444 | |
4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.444 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.443 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
2pvy | ACP | Fibroblast growth factor receptor 2 | / | 0.442 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.442 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.442 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.441 | |
3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.441 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.441 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.441 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.441 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.440 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.440 | |
2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.440 | |
3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.440 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.440 |